GSK
-
GSK in agreement to acquire late-stage biopharma company BELLUS Health
The acquisition provides GSK access to camlipixant, a potential best-in-class and highly selective P2X3 antagonist currently in phase III development…
Read More » -
Pharma giants partner with Singapore researchers to boost innovation in biologics and vaccines manufacturing
The partnership will be formalised through the Biologics Pharma Innovation Programme Singapore Leading pharma companies GSK, Sanofi and Takeda will…
Read More » -
Sanofi, GSK to conduct COVID-19 vaccine trial in India
Phase 3 clinical trial will include more than 35,000 volunteers from several countries, including sites in the US, Asia, Africa…
Read More » -
GSK, PATH, Bharat Biotech sign product transfer agreement
The agreement will help to ensure long-term supply of RTS,S/AS01E malaria vaccine GSK, PATH and Bharat Biotech (BBIL) announced the…
Read More »